About Bioptigen
Bioptigen is a company based in United States founded in 2004 was acquired by Leica Microsystems in June 2015.. Bioptigen has raised $2.79 million across 16 funding rounds from investors including Leica Microsystems and HHS. The company has 25 employees as of December 31, 2014. Bioptigen operates in a competitive market with competitors including Sensimed, i-Optics, Azul Optics, Oxymap and 2EyesVision, among others.
- Headquarter United States
- Employees 25 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioptigen Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.79 M (USD)
in 16 rounds
-
Latest Funding Round
$1.72 M (USD), Grant
Sep 30, 2014
-
Investors
Leica Microsystems
& 1 more
-
Employee Count
25
as on Dec 31, 2014
-
Acquired by
Leica Microsystems
(Jun 01, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bioptigen
Bioptigen has successfully raised a total of $2.79M across 16 strategic funding rounds. The most recent funding activity was a Grant round of $1.72 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Grant — $1.7M
-
First Round
First Round
(01 May 2004)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Grant - Bioptigen | Valuation |
investors |
|
| Sep, 2014 | Amount | Grant - Bioptigen | Valuation |
investors |
|
| Aug, 2012 | Amount | Grant - Bioptigen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bioptigen
Bioptigen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Leica Microsystems and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Imaging solutions for macro, micro, and nano structures are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioptigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bioptigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioptigen Comparisons
Competitors of Bioptigen
Bioptigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, i-Optics, Azul Optics, Oxymap and 2EyesVision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| domain | founded_year | HQ Location |
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
|
|
| domain | founded_year | HQ Location |
Device for assessing the eye health against damaging light
|
|
| domain | founded_year | HQ Location |
Retinal Imaging technology to assess retinal oxygen saturation and vessel width
|
|
| domain | founded_year | HQ Location |
Portable technologies for multifocal eye corrections before surgeries are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bioptigen
When was Bioptigen founded?
Bioptigen was founded in 2004.
Where is Bioptigen located?
Bioptigen is headquartered in United States.
Is Bioptigen a funded company?
Bioptigen is a funded company, having raised a total of $2.79M across 16 funding rounds to date. The company's 1st funding round was a Grant of $288.53K, raised on May 01, 2004.
How many employees does Bioptigen have?
As of Dec 31, 2014, the latest employee count at Bioptigen is 25.
What does Bioptigen do?
Bioptigen develops Optical Coherence Tomography (OCT) devices with Spectral domain imaging(SDI). While all OCT techniques use interferometry to create cross-sectional views of different types of tissue, the SD-OCT approach offers faster scanning speeds than the earlier time-domain approach, making it more suited to real-time surgical use. Bioptigen is an ISO 13485-certified medical device company that develops ophthalmic imaging solutions. Bioptigens Envisu R-class systems is for non-invasive ophthalmic imaging of animals. Using low-power, near-infrared light, Envisu generates real-time, volumetric images of ocular microstructures from the cornea to the retina. Bioptigen has received CE approval to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical use within the EU.
Who are the top competitors of Bioptigen?
Bioptigen's top competitors include 2EyesVision, Sensimed and Diopsys.
Who are Bioptigen's investors?
Bioptigen has 2 investors. Key investors include Leica Microsystems, and HHS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.